A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...] …
Category: Pharma Industry
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Amgen recently announced it will exempt Tennessee providers from its contract pharmacy restrictions despite a carve out in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SpecGx, a generic subsidiary of Mallinckrodt Pharmaceuticals, will refund 340B covered entities that purchased addiction treatment medication Methadose for above [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Oregon Legislature yesterday sent a 340B contract pharmacy access bill to the state’s governor, shortly after Illinois lawmakers failed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant AbbVie has sued Hawaii over its 340B contract pharmacy access law just three days after the governor signed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Department of Health and Human Services (HHS) has submitted proposed 340B rebate guidance for regulatory review—but it is unclear [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The governors of Colorado and Hawaii have signed new laws that bar drugmakers from restricting 340B contract pharmacy access and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
Trump’s Full 2026 Budget Request Would Shift 340B Program from HRSA to CMS, Maintain Current OPA Funding
President Donald Trump’s fiscal year 2026 budget request released yesterday calls for moving control of the 340B program away from [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Vermont legislature has passed a sweeping 340B bill with contract pharmacy protections, provider reporting requirements and controversial price caps [...] …